Cathie Wood says these 3 health stocks will be the backbone of $1 trillion opportunity

Catherine Wood, chief executive officer of ARK Investment Management LLC, speaks during the Milken Institute Global Conference in Beverly Hills, California, on Monday, Oct. 18, 2021.
Kyle Grillot | Bloomberg | Getty Images

Gene-editing stocks may have disappointed lately but Cathie Wood still sees them as a big opportunity for long-term investors, and highlighted three favorites.

More In Follow the Pros

CNBC ProHedge funds bought into these outperforming industrial stocks, including Lockheed Martin
CNBC ProTech investor Jim Breyer says he's adding Microsoft on weakness and will hold it for years
CNBC ProThe S&P 500 could reach 3,200 before bottoming in ‘worst-case scenario,’ Fairlead Strategies’ Stockton says